NPI: 1972741999 · DALY CITY, CA 94014 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/29/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/29/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,265 | $1.03M |
| 2019 | 11,129 | $832K |
| 2020 | 8,056 | $1.38M |
| 2021 | 5,592 | $1.40M |
| 2022 | 5,304 | $1.42M |
| 2023 | 5,293 | $1.41M |
| 2024 | 4,525 | $1.72M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 41,801 | 3,737 | $9.19M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 12,027 | 770 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,938 | 570 | $385.88 |
| J1756 | Injection, iron sucrose, 1 mg | 1,689 | 515 | $376.82 |
| 82728 | 152 | 141 | $58.88 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 21 | 13 | $51.55 |
| 85041 | 90 | 85 | $31.97 | |
| 90674 | 35 | 33 | $29.07 | |
| 83540 | 163 | 149 | $7.01 | |
| 90662 | 16 | 16 | $1.12 | |
| 83970 | 84 | 78 | $0.00 | |
| 82108 | 20 | 17 | $0.00 | |
| 85048 | 90 | 85 | $0.00 | |
| 83550 | 163 | 149 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 679 | 477 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 131 | 65 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 51 | 43 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 14 | 12 | $0.00 |